Showing results (2721-2730 of 6,794) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|March 24, 2018
Association Between Self-reported Physical Activity and Skin Autofluorescence, a Marker of Tissue Accumulation of Advanced Glycation End Products in Adults With Type 1 Diabetes: A Cross-sectional StudyAnna Duda-Sobczak, Bogusz Falkowski, Aleksandra Araszkiewicz, et al.
Clinical Therapeutics|March 24, 2018
Fetal Sex, Need for Insulin, and Perinatal Outcomes in Gestational Diabetes Mellitus: An Observational Cohort StudyStefano Raffaele Giannubilo, Angela Pasculli, Chiara Ballatori, et al.
Clinical Therapeutics|December 16, 2018
Drug Discontinuation in Studies Including a Switch From an Originator to a Biosimilar Monoclonal Antibody: A Systematic Literature ReviewGeorgios Bakalos, Elias Zintzaras
Clinical Therapeutics|April 1, 2018
Historical and Current Advances That Incorporate Competing Risk for Benefit and Mortality in Older Patients With CancerRandall W Rupper
Clinical Therapeutics|March 14, 2018
An Overview of Immune Checkpoint Inhibitors in Gynecologic CancersTara Castellano, Kathleen N Moore, Laura L Holman
Clinical Therapeutics|November 27, 2018
Effects of the Intravenous Calcimimetic Etelcalcetide on Bone Turnover and Serum Fibroblast Growth Factor 23: Post Hoc Analysis of an Open-label StudyTakashi Shigematsu, Masafumi Fukagawa, Keitaro Yokoyama, et al.
Clinical Therapeutics|February 6, 2019
Cyclophosphamide + Thalidomide + Dexamethasone Versus Melphalan + Dexamethasone for the Treatment of Amyloid Light-chain Amyloidosis With Kidney Involvement: A Retrospective Study in Chinese PatientsBaojian Liu, Yan Wang, Ming Bai, et al.
Clinical Therapeutics|March 26, 2018
Benefits and Challenges of Lung Cancer Screening in Older AdultsMeytal S Fabrikant, Juan P Wisnivesky, Thomas Marron, et al.
Clinical Therapeutics|October 9, 2007
A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitisJosefine Gradman, Mark F Caldwell, Ole D Wolthers
Clinical Therapeutics|April 28, 2009
Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety studyPaul Karpecki, Michael Depaolis, Judy A Hunter, et al.
Pageof 680